Abstract Carnitine is mainly biosynthesized in the liver and kidneys, so carnitine deficiency has occurred when liver tissue is damaged by liver diseases such as cirrhosis and non-alcoholic fatty liver disease (NAFLD), although blood free carnitine is high in most cases
Increasing number of chronic diseases such as oncology, diabetes, cardiovascular diseases, respiratory diseases, neurology disorders, orthoarthritis and many more with rising number of disorder among the people with increasing population and many more disorders with increasing number of treatments based on the small molecule API with increased efficiency of the molecule and developed infrastructures in health care sectors boost the small molecule API market to grow with rising market demand for the new innovations in medications with faster recovery propels the market of small molecule API to a larger extend
Autophagy in nonalcoholic steatohepatitis
The half-life is similar (approximately one week), but the within-dose bioavailability variation is much higher at 137% per dose
When a 95% confidence interval (CI) was available, the CI bounds were used
The prices are very competitive & they have discounts regularly so its super affordable
